Literature DB >> 31017742

Obstruction is associated with perineural invasion in T3/T4 colon cancer.

H Nozawa1, T Morikawa2, K Kawai1, K Hata1, T Tanaka1, T Nishikawa1, K Sasaki1, Y Shuno1, M Kaneko1, M Hiyoshi1, S Emoto1, K Murono1, H Sonoda1, M Fukayama2, S Ishihara1.   

Abstract

AIM: Perineural invasion (PNI) is a risk factor for recurrence and metastasis and consequently leads to decreased survival in patients with various malignancies. Recent studies showed that stent placement in obstructive colon cancer increases the frequency of PNI. We hypothesized that mechanical stress including obstruction itself may be associated with PNI.
METHOD: We retrospectively reviewed 496 patients with pathological T3 or T4 colon cancer who did not receive preoperative treatment. Data were collected from medical charts and pathological findings. The relationships between PNI and other clinicopathological factors were analysed using univariate and multivariate analyses.
RESULTS: PNI was observed in 239 (48%) patients. Obstruction was markedly more frequent in PNI-positive cancer (39%) than in PNI-negative cancer (24%, P = 0.0003). Multivariate analyses identified obstruction as one of the significant factors associated with PNI (OR 1.68, P = 0.028). Moreover, in 414 patients without distant metastasis who underwent complete resection, PNI was an independent factor associated with poor recurrence-free survival (hazard ratio 2.35, P = 0.003). The coexistence of PNI and obstruction resulted in greater decreases in recurrence-free survival than PNI-negative and/or non-obstructive cases.
CONCLUSION: Our results suggest that obstruction is associated with PNI and consequently contributes to an increased postoperative recurrence in colon cancer. Colorectal Disease
© 2019 Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  colon cancer; multivariate analysis; obstruction; perineural invasion; recurrence

Year:  2019        PMID: 31017742     DOI: 10.1111/codi.14655

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  6 in total

Review 1.  Perineural invasion is increased in patients receiving colonic stenting as a bridge to surgery: a systematic review and meta-analysis.

Authors:  I Balciscueta; Z Balciscueta; N Uribe; E García-Granero
Journal:  Tech Coloproctol       Date:  2020-11-17       Impact factor: 3.781

2.  Establishment of a Convenient System for the Culture and Study of Perineurium Barrier In Vitro.

Authors:  Xuemin Yin; Xiaohao Liu; Yan Zhang; Jiao Zeng; Xiaodan Liang; Xiaojun Yang; Jin Hou
Journal:  Cell Mol Neurobiol       Date:  2020-10-07       Impact factor: 5.046

3.  Tumor Deposits and Perineural Invasion had Comparable Impacts on the Survival of Patients With Non-metastatic Colorectal Adenocarcinoma: A Population-Based Propensity Score Matching and Competing Risk Analysis.

Authors:  Bin Luo; Xianzhe Chen; Guanfu Cai; Weixian Hu; Yong Li; Junjiang Wang
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 3.302

4.  Accelerated perineural invasion in colitis-associated cancer: A retrospective cohort study.

Authors:  Hiroaki Nozawa; Keisuke Hata; Tetsuo Ushiku; Kazushige Kawai; Toshiaki Tanaka; Yasutaka Shuno; Takeshi Nishikawa; Kazuhito Sasaki; Shigenobu Emoto; Manabu Kaneko; Koji Murono; Hirofumi Sonoda; Soichiro Ishihara
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

5.  Comparison of Clinical Outcomes and Pathological Characteristics of Self-Expandable Stent Bridge to Surgery and Emergency Surgery in Obstructive Colon Cancer.

Authors:  Bingyan Wang; Siyi Lu; Zhiqiang Song; Fei Li; Junren Ma; Yanpeng Ma; Xin Zhou; Wei Fu
Journal:  Cancer Manag Res       Date:  2020-03-09       Impact factor: 3.989

6.  Comparison of safety between self-expanding metal stents as a bridge to surgery and emergency surgery based on pathology: a meta-analysis.

Authors:  Yang Hu; Jiajun Fan; Yifan Xv; Yingjie Hu; Yuan Ding; Zhengjie Jiang; Qingsong Tao
Journal:  BMC Surg       Date:  2020-10-27       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.